Evidence map›Paper›PMID 41258006›Full record

ArticleCommunications medicine2025

First imported cases of MPXV Clade Ib from Goma, Democratic Republic of the Congo.

Daniel Mukadi-Bamuleka, Eddy Kinganda-Lusamaki, Noella Mulopo-Mukanya, Adrienne Amuri-Aziza, Áine O'Toole, Sydney Merritt, Brigitte Modadra-Madakpa, Guy Mutombo-Ndongala, Emmanuel Hasivirwe Vakaniaki, Cris Kacita and 43 more

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Community transmission of mpox clade Ib not driven through sexual exposures, Uvira, eastern Democratic Republic of the Congo, June to October 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

53 authors.

Daniel Mukadi-BamulekaService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo. drmukadi@gmail.com.ORCID http://orcid.org/0000-0002-6836-8704
Eddy Kinganda-LusamakiService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Noella Mulopo-MukanyaRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Adrienne Amuri-AzizaInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.ORCID http://orcid.org/0000-0002-5516-0779
Áine O'TooleInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-8083-474X
Sydney MerrittDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, USA.
Brigitte Modadra-MadakpaRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Guy Mutombo-NdongalaMinistry of Public Health, Hygiene and Social Welfare; Provincial Health Division, Goma, North Kivu, Democratic Republic of the Congo.
Emmanuel Hasivirwe VakaniakiInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Cris KacitaHemorrhagic Fever and Monkeypox Program, Ministry of Health, Kinshasa, Democratic Republic of the Congo.
Gaston Lubambo MabokoMinistry of Public Health, Hygiene and Social Welfare; Provincial Health Division, Goma, North Kivu, Democratic Republic of the Congo.
Jean-Claude Makangara-CigoloService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID http://orcid.org/0000-0002-1791-2247
Michel NgimbaRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Emmanuel Lokilo-LofikoInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Elisabeth Pukuta-SimbuInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Gradi Luakanda-NdelemoInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.ORCID http://orcid.org/0009-0004-0406-2361
Tavia Bodisa-MatamuRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Zephanie Paluku-KalimuliRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Prince Akil-BandaliInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Sifa Kavira-BapitaniInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Daan JansenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-4612-6891
Adèle Kavira-KamaliroRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Emile Muhindo-MilondeRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Jeriel MufungiziRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Yves Birindwa-HamisiRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Hugo KavungaRodolphe Merieux INRB-Goma Laboratory, Goma, Democratic Republic of the Congo.
Olivier TshianiInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Sabin Sabiti NunduInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Laurens LiesenborghsDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID http://orcid.org/0000-0001-5616-8548
Nicole A HoffDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, USA.ORCID http://orcid.org/0000-0002-1770-6304
Megan HalbrookDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, USA.
Robert ShongoHemorrhagic Fever and Monkeypox Program, Ministry of Health, Kinshasa, Democratic Republic of the Congo.
Ahidjo AyoubaTransVIHMI (Recherches Translationnelles sur le VIH et les Maladies Infectieuses), Université de Montpellier, Institut de Recherche pour le Développement (IRD), Institut National de Santé et de Recherche Médicale (INSERM), Montpellier, France.
Genay PilarowskiChan Zuckerberg Biohub, San Francisco, USA.ORCID http://orcid.org/0000-0001-8270-8771
Alain Kakule MangolopaWorld Health Organization, DRC country Office, Kinshasa, Democratic Republic of the Congo.
Amos Kiuka EbondoWorld Health Organization, DRC country Office, Kinshasa, Democratic Republic of the Congo.
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Souradet Y ShawCollege of Community and Global Health, University of Manitoba, Winnipeg, Canada.
Sam WilkinsonUniversity of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-6944-5927
Sofonias Kifle TessemaAfrica Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0003-1057-5310
Lorenzo SubissiWorld Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-5147-575X
Eric DelaporteTransVIHMI (Recherches Translationnelles sur le VIH et les Maladies Infectieuses), Université de Montpellier, Institut de Recherche pour le Développement (IRD), Institut National de Santé et de Recherche Médicale (INSERM), Montpellier, France.
Koen VercauterenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-1472-9938
Tony Wawina-BokalangaService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Anne W RimoinDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, USA.ORCID http://orcid.org/0000-0002-0662-9067
Lisa E HensleyUS Department of Agriculture, Agricultural Research Service, Manhattan, USA.
Martine PeetersTransVIHMI (Recherches Translationnelles sur le VIH et les Maladies Infectieuses), Université de Montpellier, Institut de Recherche pour le Développement (IRD), Institut National de Santé et de Recherche Médicale (INSERM), Montpellier, France.
Nicholas LomanUniversity of Birmingham, Birmingham, UK.
Andrew RambautInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-4337-3707
Jean-Jacques Muyembe-TamfumService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jason KindrachukDepartment of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, Canada. Jason.Kindrachuk@umanitoba.ca.ORCID http://orcid.org/0000-0002-3305-7084
Placide Mbala-KingebeniService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo. mbalaplacide@gmail.com.ORCID http://orcid.org/0000-0003-1556-3570
Steve Ahuka-MundekeService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.

Funding

Emerging Infectious Diseases Research Center - East and Central AfricaU01AI151799 · NIAID · WASHINGTON STATE UNIVERSITY · PI M KARIUKI NJENGA · 2020 to 2026
$10.4M
Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) MRR-184813International Development Research Centre (Centre de recherches pour le développement international) MRR-184813NIAID NIH HHS U01 AI151799Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

backgroundThe ongoing mpox outbreaks in the Democratic Republic of the Congo (DRC) resulted in >71,000 suspected cases from 01 January 2024 to 02 February 2025. Clade Ib mpox virus (MPXV) emergence has heightened public health concern due to observed sustained human-human transmission and spread to multiple non-endemic East African countries. Clade Ib outbreaks have been marked by epidemiologic deviations from classic Clade Ia zoonotic transmission-Clade Ib instead has been observed among adult populations and transmission via sexual contact. With the continued expansion of Clade Ib across the region, containment and mitigation measures may need to be adapted to best fit this novel MPXV clade.

methodsCase investigation and epidemiological assessment data as well as whole viral geonome sequencing was analyzed from confirmed mpox infected individuals in the Goma region. Case demographics and clinical presentation data was also assessed from suspected mpox cases in the region.

resultsWe report the first introduction of Clade Ib into North Kivu province through close contact transmission. We also report limited human-human Clade Ib transmission chains among children <15 years in the Mudja internal displaced persons camp. We further present evidence of APOBEC3 mutations and genomic links between these North Kivu cases with the larger ongoing Clade Ib outbreak in Kamituga, South Kivu.

conclusionsGiven the expansion of regional mpox outbreaks and populations considered at-risk, these findings underscore how mpox case investigations and community messaging should include considerations for non-sexual human-human transmission of Clade Ib that includes children <15 years.

Identifiers

PMID41258006
PMCPMC12647660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.